Arachidonate metabolism in vascular disorders.
D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism*; D001241:Aspirin / Q000494:pharmacology / Q000627:therapeutic use; D001792:Blood Platelets / Q000502:physiology; D001808:Blood Vessels / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D016861:Cyclooxygenase Inhibitors; D004305:Dose-Response Relationship, Drug; D004727:Endothelium / Q000378:metabolism; D011464:Epoprostenol / Q000096:biosynthesis; D005231:Fatty Acids, Unsaturated / Q000096:biosynthesis*; D005343:Fibrinolytic Agents; D006801:Humans; D013928:Thromboxane A2 / Q000096:biosynthesis; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors; D014652:Vascular Diseases / Q000188:drug therapy / Q000378:metabolism*
D001095:Arachidonic Acids; D016861:Cyclooxygenase Inhibitors; D005231:Fatty Acids, Unsaturated; D005343:Fibrinolytic Agents; D016718:Arachidonic Acid; D013928:Thromboxane A2; D011464:Epoprostenol; D000242:Cyclic AMP; D013930:Thromboxane-A Synthase; D001241:Aspirin